AstraZeneca opens new global R&D center in Kendall Square, Cambridge
The center builds on AstraZeneca's existing presence in Cambridge and Boston and places its scientists in a life sciences ecosystem.
GetSignal AstraZeneca PLC AZN
AstraZeneca announced on October 5, 2026, the opening of its newest global strategic research and development center in Kendall Square, Cambridge, Massachusetts.
Key facts
- Location
- Kendall Square, Cambridge, Massachusetts
- Facility
- Global strategic research and development center
- Announced
- October 5, 2026
Source: The company's release on Business Wire, October 5, 2026.
Written by GetSignal with AI from the company's press release.
Not investment advice.
